Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Germany

 

Synlab to IPO in Frankfurt

Europe's largest lab group Synlab will list on the Frankfurt Stock Exchange in Q2 after releasing an intention to float document on Wednesday morning. The group says revenue will grow 17% this year to €3bn+ revenue and that COVID-19 revenue will only continue to grow.
April 7, 2021

Swiss Life buys German care home portfolio

Luxembourg-based private equity firm Threestones Capital has sold its portfolio of 27 German care home properties to real estate manager Swiss Life Asset Managers for €425m.
March 18, 2021

EMEA for-profit hospital sector shrinks 3-5% in 2020

Revenues in the EMEA for-profit hospital market fell by 3-5% in 2020 due to COVID-19 but could bounce back strongly in 2021, figures from HBI Intelligence show. NMC Health CEO Michael Davis tells HBI he anticipates a ‘return to normalcy’ to continue through the year. 
March 11, 2021

Triton “invests” in Bergman – Aleris merger to follow?

PE firm Triton has agreed to "invest" in Dutch, Nordic and German ambulatory clinic operator Bergman Clinics, possibly implying it is not buying control from NPM Capital and the Malensteins who are retaining stakes. Triton would not comment on the size of the stake nor on our speculation it plans to merge Bergman with Nordic operator Aleris.
March 11, 2021

Vaccines causing minimal headwinds in COVID-19 testing volumes

HBI analysis of COVID-19 testing volumes and pricing reveals how vaccine programmes and the rise of antigen tests might impact future growth for the lab groups. PCR volumes and have dropped 16% in the UK since it started vaccinating its population and one lab group is expecting a 35% to 50% drop in COVID revenue this year.
March 11, 2021

EMEA hospital sector finishes 2020 strongly

Private hospital operators across Europe, the Middle East and South Africa had a good last few months of trading in what was a turbulent 2020, but the start of 2021 looks tougher. We talk to operators across the region.
February 25, 2021

Amedes for sale as Synlab forecasts future organic growth to settle about 3%

Europe's largest lab group Synlab forecasts that it will see 3+% of annual organic growth over the mid-term, saying that testing will remain a core part of pandemic control. Other lab groups clearly agree with that punt, with news that smaller rival Amedes reportedly is preparing for sale.
February 25, 2021
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us